Dow Up 0.76% Nasdaq Up 0.69%

Actavis plc (ACT)

-NYSE
240.33 Up 3.12(1.32%) 4:03PM EDT
|After Hours : 240.33 0.00 (0.00%) 4:57PM EDT
Prev Close:237.21
Open:237.16
Bid:239.20 x 200
Ask:246.00 x 1000
1y Target Est:268.14
Beta:0.34
Next Earnings Date: 5-Nov-14ACT Earnings announcement
Day's Range:236.19 - 240.85
52wk Range:144.91 - 249.94
Volume:1,363,235
Avg Vol (3m):2,405,430
Market Cap:63.51B
P/E (ttm):630.79
EPS (ttm):0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTUp 1.32%63.51B
MYLUp 1.57%19.16B
NVSUp 1.02%218.72B
TEVAUp 0.04%45.78B

Key Statistics

Forward P/E (1 yr):14.67
P/S (ttm):6.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.29
Quarterly EPS Est (Sep-14) :3.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback